339539-88-7 Usage
Chemical structure
A complex molecule with several functional groups, including an amino acid unit, a piperidine ring, a benzyl group, and a hydrazide group.
Indole ring
Contains an indole ring, which is commonly found in many natural products and pharmaceuticals.
Stereochemistry
The molecule has two chiral centers, with the (2R) and (3R) configurations.
Potential biological activity
Due to its multiple functional groups and complex structure, it may have potential biological activity and be an interesting target for further investigation in medicinal chemistry and drug discovery.
Functional groups
The molecule contains various functional groups, including an amino group, a carboxylic acid group, and a hydrazide group.
Molecular weight
The molecular weight of the compound is approximately 464.59 g/mol.
Stability
The stability of the compound may be affected by factors such as temperature, pH, and the presence of other molecules or ions.
Synthesis
The synthesis of the compound may involve the formation of the various functional groups and the assembly of the molecule through chemical reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 339539-88-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,9,5,3 and 9 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 339539-88:
(8*3)+(7*3)+(6*9)+(5*5)+(4*3)+(3*9)+(2*8)+(1*8)=187
187 % 10 = 7
So 339539-88-7 is a valid CAS Registry Number.
339539-88-7Relevant academic research and scientific papers
A practical synthesis of the pseudotripeptide RC-1291
Paul, Bernhard J.,Littler, Benjamin J.,Jos, Frederic,Vogt, Paul F.,Pines, Seemon H.
, p. 339 - 345 (2012/12/22)
The rapid process development of a scaleable synthesis of the pseudotripeptide RC-1291 for preclinical and clinical evaluation is described. By employing a nontraditional N-to-C coupling strategy, the peptide chain of RC-1291 was assembled in high yield, with minimal racemization and in an economical manner by introducing the most expensive component last. A one-pot deprotection/crystallization procedure was developed for the isolation of RC-1291 free base, which afforded the target compound in excellent yield and with a purity of >99.5% without chromatographic purification.
Compound with growth hormone releasing properties
-
, (2008/06/13)
The present invention describes a new compound, 2-Amino-N-[(1R)-2-[(3R)-3-benzyl-3-(N,N′,N′-trimethylhydrazinocarbonyl)piperidin-1-y]-1-(1H-indol-3-ylmethyl)-2-oxoethyl]-2-methylpropionamide, having the formula: and pharmaceutically acceptable salts thereof, compositions containing them, and their use for treating medical disorders resulting from a deficiency in growth hormone.
